Taflotan

Taflotan

tafluprost

Manufacturer:

Santen Pharma

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Tafluprost
Indications/Uses
Reduction of IOP in patients w/ primary open-angle glaucoma or ocular HTN.
Dosage/Direction for Use
Instill 1 drop in affected eye(s) once daily.
Contraindications
Special Precautions
Patients w/ aphakia or pseudoaphakia, endophthalmitis; blepharal pigmentation or hypertrichosis; corneal epithelium disorder; closed-angle glaucoma. History of bronchial asthma. Remove contact lens prior to administration & reinsert after 15 min. Concomitant use w/ other topical ophth drugs. Temporary blurred vision may develop. May affect ability to drive & use machines. Pregnancy. Avoid use during lactation. Low birth wt infants, neonates, infants or childn. Elderly.
Adverse Reactions
Conjunctival inj, abnormalities in eyelashes, itching, eye irritation, iris & blepharal pigmentation, corneal epithelium disorder, eyelid hypertrichosis.
MIMS Class
Antiglaucoma Preparations
ATC Classification
S01EE05 - tafluprost ; Belongs to the class of prostaglandin analogues. Used in the treatment of glaucoma.
Presentation/Packing
Form
Taflotan ophth soln 15 mcg/mL
Packing/Price
2.5 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in